Selpercatinib
Product name:LOXO-292
CAS No.:2152628-33-4
MF:C29H31N7O3
MW:525.6
EINECS No.:207-854-9
Grade:pharma grade
CAS No.:2152628-33-4
MF:C29H31N7O3
MW:525.6
EINECS No.:207-854-9
Grade:pharma grade
AP051
Quantity
Selpercatinib is a targeted anti-cancer drug that acts on the kinase activity of RET protein.
RET gene mutation or rearrangement is the driving factor of many cancers.
Selpercatinib is mainly used to treat thyroid cancer, non-small cell lung cancer, breast cancer.
It can be used as a first-line treatment drug, as well as for the treatment of advanced or metastatic
RET gene mutation or rearrangement is the driving factor of many cancers.
Selpercatinib is mainly used to treat thyroid cancer, non-small cell lung cancer, breast cancer.
It can be used as a first-line treatment drug, as well as for the treatment of advanced or metastatic
cancer patients.
Selpercatinib is primarily used to treat many types of cancer, including non-small cell lung cancer, colorectal cancer.
